We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Hebei Bolente Pharmaceutical Co., Ltd. is a high-tech enterprise, founded by a team of returnees from overseas study, including experts of the national "Thousand Talents Plan", experts of the "Hundred Talents Plan" for high-level overseas students in Hebei Province, and R&D, engineering, technology and management personnel with many years of practical experience. Borent Pharmaceutical has obtained ISO9001:2008 quality management system, ISO14000 environmental management system and OHSAS18000 occupational safety and health system certification, with safety production license and three wastes emission permit certificate. It has built a chemical - biological - environmental protection - pharmaceutical research and development platform, a pilot - pilot - industrialization transformation platform, and a production-learning-research cooperation platform. The company takes technology research and development as the leading role, develops high-tech pharmaceutical intermediates/chiral compounds, and creates core technologies such as chiral synthesis, chemical/enzyme catalysis, and clean production process. The products are mainly based on the foreign high-end market, and for the production of domestic apis supporting intermediates. The company has strong research and development strength, and has established strategic cooperative relations with many companies at home and abroad, and achieved win-win results with customers in various ways such as order production, commissioned processing, customized synthesis, and cooperative research and development. The company has completed more than 100 research and development projects and technical reserves, and some products have realized industrial production. At present, there are more than 10 authorized invention patents. The company has a sound safety management system and complete safety facilities. The company also has a perfect three wastes treatment device, three wastes after treatment are discharged up to standard. Adhering to the development concept of open cooperation, honesty and credibility, and innovation, the company is committed to creating a win-win cooperation platform for domestic and foreign pharmaceutical elite enterprises, and sincerely look forward to cooperating with people with lofty ideals, pharmaceutical manufacturers and scientific research institutes committed to innovation and development to create brilliance.
One year of qualification
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
